Power Paper

Power Paper ("Power Paper" or "the Company") is a leading developer of breakthrough active patches that deliver cosmetic and pharmaceutical formulations for skincare and dermal diseases. The Company's disposable, non-invasive patches exponentially increase the penetration of cosmetic or topical formulations into the skin, thereby significantly enhancing the efficacy of the desired results. Power Paper's products are based on its printable, ink-based energy cells, which have been in development for over a decade, and are covered by 62 patents (granted and pending). The company develops patches addressing various cosmetic applications; anti-aging, antiwrinkle, skin whitening, anti-cellulite, acne and more. Pharmaceutical applications are also under development in collaboration with numerous partners. These product are sold worldwide by a vast network of cosmetics companies and distributors, including top-tier customers such as Estee Lauder, Amore Pacific and Dior. Using its proven technology platform, Power Paper is developing a number of therapeutic patch products to deliver pharmaceutical agents deep into the skin. The first of such segments that the Company is currently under initial stage of development is that of treatment of onychomycosis(nail fungus), an affliction that affects more than 30 million people in the U.S. alone. Feasibility proof-of-concept studies have demonstrated significant benefits of Power Paper's patch on nail appearance. Power Paper will generate approximately $3 million in revenues in 2007, with expected growth to $56 million by 2010. Founded in 1998, Power Paper is a well-established company with a mature core technology and management team. The Company's investors include top-tier venture capital firms, including Apax Partners (UK), Infinity (Israel), Amadeus Capital Partners (UK).